Promising drug combo shows hope for slowing aggressive gut tumors
Disease control
Ongoing
This study tests whether adding Lutathera to standard octreotide therapy can delay tumor growth in people with advanced neuroendocrine tumors of the stomach, intestines, or pancreas. The trial involves 226 patients with fast-growing tumors (grades 2 and 3) who have not received p…
Phase: PHASE3 • Sponsor: Advanced Accelerator Applications • Aim: Disease control
Last updated May 03, 2026 23:03 UTC